Exscientia Plc

Exscientia plc operates as a biotechnology company. The Company develops an artificial intelligence-designed drug candidates to progress into clinical trials, as well as the first clinically-validated AI-driven platform to improve treatment outcomes for cancer patients. Exscientia serves customers in the United Kingdom.